Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00699426 | The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes | PHASE3 | COMPLETED | 41 | — | — | Jun 1, 2008 | Jun 1, 2009 | Sep 3, 2012 | - | — |
| Arm | Type | Description |
|---|---|---|
| Nexium + Yoghurt | ACTIVE_COMPARATOR | - |
| Nexium + Placebo | PLACEBO_COMPARATOR | - |
| Placebo+ Yoghurt | PLACEBO_COMPARATOR | - |
| placebo+placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| nexium | DRUG | 40 mg once daily is tested together with Yoghurt |
| Yoghurt | DIETARY_SUPPLEMENT | Yoghurt |
| placebo+placebo | DRUG | placebo and placebo are tested. |
Inclusion Criteria: * Type 2 diabetes (WHO criteria) treated with metformin and/or sulfonylureas or diet * Males and females between 40 and 70 years * HbA1c between 6,0-10,0 * Diabetes duration \> 1 year Exclusion Criteria: * Kidney disease (s-creatinine above the upper limit of normal range). * ...